• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$40.88 $1.34 (3.39%)

REAL-TIME: Last trade at

Par Pharmaceutical Companies, ...

NYSE:PRX

Jump to this page for:

Related Resources

Par Pharmaceutical Q1 net loss decreases

5/23/2012 by Datamonitor

Activist Investor Pushes Par Pharmaceutical, Inc. to Consider Selling Itself

5/10/2012 by BioSpace

Par Pharma Beats on All Fronts

5/9/2012 by Zacks Equity Research Analyst Blog

Par Pharma Beats on All Fronts - Analyst Blog

5/9/2012 by Zacks Investment Research

Par Pharma Beats on All Fronts - Analyst Blog

5/9/2012 by NASDAQ

UBS Maintains a 'Buy' on Par Pharmaceutical (PRX); Comments From Conference Call

5/9/2012 by StreetInsider.com

Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Generic Core Delivers; Substantial Upside with Lovaza on Horizon

5/9/2012 by StreetInsider.com

Par Pharmaceutical (PRX) Tops Q1 EPS by 8c

5/8/2012 by StreetInsider.com

Par Pharmaceutical reports Q1 Metoprolol sales $61.8M

5/8/2012 by Theflyonthewall.com

Par Pharmaceutical reports Q1 EPS 80c, consensus 73c

5/8/2012 by Theflyonthewall.com

Relational raises stake in Par Pharma to 9.9%

5/7/2012 by MarketWatch

Relational raises stake in Par, says gaining confidence in actions

5/7/2012 by Theflyonthewall.com

Par Pharmaceutical, DOJ "optimistic" of Megace ES settlement, DJ reports

5/1/2012 by Theflyonthewall.com

Biotechnology And Drugs Stocks To Watch Next Week

5/1/2012 by Seeking Alpha

Par Pharmaceutical Acquires Rights To Market And Distribute Generic Dexilant® In The U.S.

4/22/2012 by Biocompare

Par Pharmaceutical Acquires Rights To Market And Distribute Generic Dexilant® In The U.S.

4/20/2012 by Pharmaceutical Online

Needham & Company Maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Healthy Deal with Handa

4/20/2012 by StreetInsider.com

Piper Jaffray Starts Par Pharmaceutical (PRX) at Overweight

4/20/2012 by StreetInsider.com

Par Pharma Acquires Handa's ANDA - Analyst Blog

4/20/2012 by Zacks Investment Research

Par Pharmaceutical initiated with an Overweight at Piper Jaffray

4/19/2012 by Theflyonthewall.com

Par Pharmaceutical Acquires Rights to Market and Distribute Generic Dexilant® in the U.S.

4/19/2012 by StockWatch

Par Pharmaceutical acquires rights to distribute generic Dexilant in U.S.

4/19/2012 by Theflyonthewall.com

Par Pharmaceutical Acquires Rights to Market and Distribute Generic Dexilant® in the U.S.

4/19/2012 by PR Newswire

Teva unit wins appeal versus Mylan, Par Pharmaceutical over generic Amrix

4/16/2012 by Theflyonthewall.com

Par Pharma Launches Generic Provigil - Analyst Blog

4/11/2012 by NASDAQ

Par Pharma Launches Generic Provigil - Analyst Blog

4/11/2012 by Zacks Investment Research

Par Pharma Launches Generic Provigil

4/11/2012 by Zacks Equity Research Analyst Blog

DepoMed files lawsuit against Impax, Par Pharmaceutical

4/11/2012 by Theflyonthewall.com

Par Pharmaceutical Companies to Report First Quarter 2012 Results on May 8, 2012

4/9/2012 by PR Newswire

Par Pharmaceutical initiates shipment of generic sleep disorder drug

4/9/2012 by Pharmaceutical Business Review Online - UK

Par Pharma starts selling generic Provigil

4/6/2012 by Pharmaceutical Processing

Par Pharmaceutical begins shipment of generic Provigil

4/6/2012 by Theflyonthewall.com

Par Pharmaceutical Begins Shipment of Generic Provigil®

4/6/2012 by StockWatch

Par Pharmaceutical Begins Shipment of Generic Provigil®

4/6/2012 by PR Newswire

URL Pharma Unit Sues Par Pharmaceutical Over Drug Patents

4/4/2012 by Bloomberg.com

Teva unit files suit related to generic versions of Provigil

4/4/2012 by Theflyonthewall.com

WCG, CL, SJM, PRX Hit 52-Week Highs

3/30/2012 by TheStreet.com

Horizon Pharma, Inc. Files Patent Infringement Lawsuit Against Par Pharmaceutical, Inc. for Filing an ANDA Against DUEXIS(R)

3/29/2012 by BioSpace

Horizon Pharma (HZNP) Files Patent Infringement Suit Against Par Pharma (PRX) Over DUEXIS Tabs

3/28/2012 by StreetInsider.com

Horizon Pharama files patent infringement suit against Par Pharmaceutical

3/28/2012 by Theflyonthewall.com
See More Articles...